Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on ALPHA REAL TRUST LTD. We currently have 7 research reports from 2 professional analysts.
|27Mar17 15:51||RNS||Admission to Trading|
|27Mar17 07:00||RNS||Proposed Delisting of IMPT|
|22Mar17 07:00||RNS||Form 8.3 - Industrial Multi Property Trust PLC|
|21Mar17 07:00||RNS||IMPT Request for EGM|
|20Mar17 17:46||RNS||Form 8.3 - Industrial Multi Property Trust plc|
|13Mar17 07:00||RNS||Statement re offer from Hansteen Holdings plc|
|09Mar17 17:01||RNS||IMPT Results Announcement|
Frequency of research reports
Research reports on
ALPHA REAL TRUST LTD
ALPHA REAL TRUST LTD
Panmure Morning Note 12-02-16
12 Feb 16
The group's announcement of acquiring a development site for a biomass plant represents a new departure for the group but upholds the strategy of investing in high yielding long term income streams. The investment is supported by the Renewable Heat Incentive and the renewable Obligation. The timing is yet to be confirmed but the investment will not be accretive to earnings in the short term. We retain our BUY and 99p target price.
Panmure Morning Note 09-12-15
09 Dec 15
This £3.75m acquisition of a site in Monk Bridge, Leeds which has planning for 269 apartments, gives greater scale to the group's private rented sector (PRS) development pipeline. Leeds is a vibrant university city which is expected to see robust appreciation in house prices and rental values over the coming years. The consideration will be satisfied with internal cash resources. We retain our BUY recommendation and 99p target price.
Panmure Morning Note 20-11-15
20 Nov 15
The interim results demonstrate the continued progress the group is making on realising robust returns from its mix of property and financial instrument investments. The repayment of the Europip mezzanine debt is enabling the group to evolve the portfolio into a good balance of high yielding assets and those which offer good development potential. 94% of the assets now generate income. The NAV/s progression of 9.1% over the first half underlines the potential in the investments. We are raising our target price to 99p and retain our Buy recommendation
Panmure Morning Note 18-08-15
18 Aug 15
The group has produced a solid start to FY16 with a 14% increase in dividend to 0.6p underlining management confidence. The asset quality, which is high yielding, is improving and so we believe that the shares will continue to rally toward the NAV/s of 113p. We are raising our target price to 90p (from 79p), or a 20% discount to the Net Asset Value, and retain our Buy recommendation.
28 Mar 17
ClearStar* (CLSU): Building a background for growth (CORP) | Sound Energy (SOU): TE-8 results (HOLD) | LiDCO* (LID): 2017 should be a transformative year (CORP) | Proteome Sciences* (PRM): FY 2016 in line. Moving towards breakeven (CORP) | Fulcrum (FCRM): Significant market potential, rising margins and a strong balance sheet (BUY) | Mortgage Advice Bureau (MAB1): Strong and growing intellectual property (BUY) | 7digital* (7DIG): Open offer result (CORP)
Another positive verdict
20 Mar 17
Burford’s results for 2016 produced another outstanding set of figures. Revenue grew by 60% to $163.4m with strong growth in the litigation finance business and an additional boost from a secondary sale in the Petersen case. On an underlying basis net income grew to $114m, a 75% increase despite the investment in growing capacity which increased costs. A combination of ongoing investment and gains and increases on valuation saw the fair value of the litigation assets increase 67% to $559m, underpinned by a growth in invested capital to $394m. With the results statement there was an announcement of a further sale of 9% of the Petersen case at a valuation of 20 times the cost of investment.
Small Cap Breakfast
28 Mar 17
Path Investments—Publication of prospectus from the Energy Investment Company. Raising £1.4m. Admission due on or around 30 March | Franchise Brands—Schedule 1 detailing £28m reverse takeover of Metro Rod. Admission expected 11 April | Alpha FX Group— Schedule 1 from the foreign exchange provider focused on managing exchange rate risk for UK corporates that trade internationally. Fundraise TBC. Admission expected 7 April. | K3 | Capital Group—Schedule 1 from the Group of business and company sales specialists across business transfer, business brokerage and corporate finance. Admission date and fundraise details TBC. | Integumen— Schedule 1 from the personal health company developing and commercialising technology and products for the human integumentary system. Raising £2.16m at 5p. Expected market cap £8.16m. Admission expected 5 April. Tufton | Oceanic Assets– Offer extended to 9 May to enable investors to complete further due diligence.